Stay updated on Reslizumab in EGPA: Clinical Trial
Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.

Latest updates to the Reslizumab in EGPA: Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor site update that does not change the study details shown on the page.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new page/version release. No visible study content changes are described in the provided data.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, signaling a new page build. This update reflects a platform or asset patch rather than changes to the study data or presentation of the trial details.SummaryDifference0.1%

- Check78 days agoChange DetectedNew navigation and guidance links were added to help users check eligibility, locate contact information, read the study record, and learn how to join the study. A formatting tweak to the Intervention/Treatment header and a revision tag update from v3.5.5 to v3.6.0 were applied.SummaryDifference0.5%

- Check85 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This indicates a new deployment or update to the page without changing the study information.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page now displays a new revision tag (Revision: v3.5.4), indicating an administrative update to the page.SummaryDifference0.1%

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.